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a b s t r a c t
To deepen our understanding of early rectal transmission of HIV-1, we studied virus–host interactions in
the rectal mucosa using simian immunodeﬁciency virus (SIV)-Indian rhesus macaque model and mRNA
deep sequencing. We found that rectal mucosa actively responded to SIV as early as 3 days post-rectal
inoculation (dpi) and mobilized more robust responses at 6 and 10 dpi. Our results suggest that the
failure of the host to contain virus replication at the portal of entry is attributable to both a high-level
expression of lymphocyte chemoattractant, proinﬂammatory and immune activation genes, which can
recruit and activate viral susceptible target cells into mucosa; and a high-level expression of SIV
accessory genes, which are known to be able to counter and evade host restriction factors and innate
immune responses. This study provides new insights into the mechanism of rectal transmission.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Anal–rectal mucosa is an important portal for HIV-1 entry in both
men and women, and especially among menwho have sex with men
(MSM). MSM have a higher risk of contracting HIV-1 infection in
both developed and developing countries than any other population
(CDC, 2011; van Griensven and de Lind van Wijngaarden, 2010).
It has been estimated that one-half to two-thirds of MSM participate
in anal intercourse (Mansergh et al., 2001; McGowan, 2008), and up
to 40% of heterosexual men and 35% of women engage in anal
intercourse (Kingsley et al., 1987; van Griensven and de Lind van
Wijngaarden, 2010). While the single columnar epithelial mucosal
barrier and abundant HIV-1-susceptible target cells in the rectum
may explain the increased rate of acquisition, the actual mechanisms
have not been determined and the current knowledge about the
earliest virus–host interactions in anorectal transmission is limited.
It has been demonstrated that both lamina propria and epithelial
cells of rhesus small intestines at 3 weeks post-SIV infection have
robust transcriptional responses (Mohan et al., 2012, 2013); however,
the host responses in days post-infection via rectal route, especially
at the portal of entry, remain unknown. To better understand the
earliest events of HIV-1 rectal transmission, we studied early virus–
host interactions in rectal mucosa of rhesus macaques intra-rectally
inoculated with simian immunodeﬁciency virus (SIV), the best
available model of human rectal transmission of HIV-1 (Keele et al.,
2009). Our study revealed profound changes in rectal mucosal gene
expression as early as 3 days post-inoculation (dpi) using next-
generation RNA sequencing (mRNA-seq), a time point before sys-
temic viral dissemination, as compared with uninfected macaques.
Importantly at 3 dpi, chemokine CCL13/MCP-4 and CCL20/MIP-3α
genes, which are well-known chemoattractants for T cells, mono-
cytes and plasmacytoid dendritic cells, were up-regulated. At 6 and
10 dpi, a greater number of genes were signiﬁcantly altered in
expression, including proinﬂammatory, immune activation, chemoat-
tractant for lymphocytes, and interferon-stimulated genes (ISGs)
targeting various steps of the viral replication life cycle. Despite the
strong mucosal anti-viral responses, the virus still subdued the
host. Our data suggest that the key tactic the virus used to evade
the mucosal host antiviral responses may be through high-level
expression of SIV accessory genes and inducing chemoattractant,
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proinﬂammatory as well as immune activation genes. Together, this
ﬁrst comprehensive genome wide study of early virus–host interac-
tion in rectum provides new insights into the mechanism of rectal
transmission and identiﬁes potential targets for future studies
Results
To elucidate the virus–host interaction in rectal mucosae during
early rectal SIV transmission, mRNA-seq was used to simultaneously
measure host and virus gene expression. Host genes with differential
expression (adjusted p-valueo0.05, fold change42) were identiﬁed
(Supplemental Table 1) and used for analysis. At 3 dpi, while SIV viral
RNAs were detectable in the rectum by both quantitative RT-PCR and
in situ hybridization (ISH), but not in distal lymph nodes and blood
(manuscript in preparation), SIV viral RNAs were not detected in the
rectum by RNA-seq, indicating SIV was only replicating locally and at
low-level in this time point and RNA-seq is less sensitive to detect
low-levels of viral RNA than RT-PCR and ISH. At 6 and 10 dpi, SIV
vRNAwas detected in rectum, blood and distal lymph nodes of all the
rhesus macaques by RT-PCR and ISH (manuscript in preparation);
furthermore SIV viral RNAs in the rectumwere also detected by RNA-
seq, and the read counts at 10 dpi are higher than 6 dpi (Fig. 5). The
mRNA-seq analyses showed that host rectal mucosa responded to SIV
as early as 3 dpi, with 116 (66.7%) genes up-regulated and 58 (33.3%)
genes down-regulated (Fig. 1A). At day 6, there were 585 differentially
expressed genes (DEGs), among which 320 (54.7%) were up-regulated
and 265 (45.3%) were down-regulated. The largest number of DEGs
occurred at 10 dpi, with 943 (65.1%) up-regulated and 506 (34.9%)
down-regulated. Both unique and shared DEGs between each time
point were observed, with 47 (3 dpi), 310 (6 dpi) and 1155 (10 dpi)
unique genes (Fig. 1B and Supplementary Fig. 1). Notably, there was a
clear preponderance of unique and shared DEGs during the course of
infection, reﬂecting the enhanced host's responses to infection over
time. To better understand the biological functions of the altered
genes and their associated signaling pathways in the context of early
rectal SIV transmission, DEGs were further classiﬁed (Fig. 2). There
were 37.9% (66/174), 26.8% (157/585) and 46.7% (677/1449) of DEGs
classiﬁable at 3, 6 and 10 dpi, respectively.
Host rectal mucosal responses at 3 dpi
As early as 3 dpi, the rectal mucosae of SIV-infected macaques
exhibited dramatic changes in gene expression as compared with
uninfected control macaques (Fig. 2A). The DEGs encoded proteins
involved in apoptosis (CIDEC and TNFRSF12A), cell adhesion
(MSLN and THBS1), gene expression (FOSB and NR4A1), inﬂam-
mation, cell metabolism and maintenance. Importantly, chemo-
kine CCL13/MCP-4 and CCL20/MIP-3α, which are well-known
chemoattractants for T cells, monocytes and plasmacytoid den-
dritic cells, were up-regulated at 3 dpi. In addition to the genes
encoding immune cell attractants, immune activation genes
(NOS2, CD1D, CNTFR and FDCSP) were also up-regulated. Notably,
FDCSP, which encodes a secreted protein in activated follicular
dendritic cells (FDCs), was further up-regulated 3.7- and 10.7-fold
at 6 dpi and 10 dpi respectively, suggesting activation and prolif-
eration of FDCs in rectal tertiary follicular aggregates.
Genes involved in cell metabolism and maintenance accounted
for most of the DEGs at 3 dpi. These genes encode for proteins
involved in the transportation of water (AQP8), iron (NKAIN4),
chloride (CLIC6), sodium (SCNN1G) and other solutes (SLC6A20,
SLC9A3, SLC26A2 and SLC6A14) across the cell membrane and
protein modiﬁcation (SGK1). Several DEGs encode for proteins
involved in metabolism of lipids (MOGAT2, CYP1A1, THRSP, SCD,
HMGCS2, LPL, ACSL1, FASN, ADIPOQ), carbohydrates (GCK,
B4GALNT2, PFKFB1), proteins (MEP1B, MEP1A, KLK15, GZMA),
alcohol (ADH4, ADH1B) and others (CDO1, FMO3, MOSC1, GPD1).
More active rectal responses at 6 and 10 dpi
Consistent with the elevated viral load and systemic dissemination
of SIV at 6 and 10 dpi, there was signiﬁcantly increased number of
DEGs as compared with 3 dpi. Although the genes involved in cell
metabolisms and maintenance still accounted for most of the DEGs,
we will mainly discuss the immune-related genes below.
The activation of pattern recognition receptors
Innate immune responses are triggered by host's pattern
recognition receptors (PRRs) bound to pathogen-associated mole-
cular patterns (PAMPs). Four PRR genes (RIG-I, LGP2, MDA5 and
DDX60) were up-regulated at 6 dpi, of which RIG-I and MDA5
were up-regulated 7- and 4.6-fold, respectively, and LGP2, a
protein homologous to RIG-I and MDA5, was up-regulated 3.7-
fold (Fig. 2B and Fig. 3). Surprisingly, at 10 dpi, in addition to PRRs
for virus recognition (RIG-I, MDA5, LGP2, TLR3 and TLR7), PRRs
recognizing bacterial patterns (MARCO, NOD2 and TLR2) were also
up-regulated (Figs. 2C and 3). In addition to viral RNA recognition,
genes involved in viral DNA recognition (DAI, IFI16 and AIM2)
were up-regulated (Figs. 2C and 3), indicating activation of viral
DNA pattern recognition by the presence of SIV DNA in rectal
mucosa.
Fig. 1. Differentially expressed genes/transcripts in rectal mucosae of SIV-infected macaques at 3, 6 and 10 dpi. (A) Number of up- and down-regulated genes at each time
point as compared with uninfected control macaques. (B) Uniquely and commonly altered genes at each time point. Up-regulated genes are depicted in red and down-
regulated genes in blue.
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Antiviral and IFN signaling activation
Among the DEGs, IFN signaling activation stood out at both 6 and
10 dpi (Fig. 2B and C), most of which were IFN-stimulated genes
(ISGs) with anti-viral activities. To better understand the functions of
these ISGs, we illustrated them in the context of IFN signaling
pathways (Fig. 3). At 10 dpi, which was around the peak of viral
replication in the rectum, the number of DEGs and the magnitude of
up-regulation were signiﬁcantly increased as compared with 6 dpi.
Fig. 2. Functional categorization of differentially expressed genes in rectal mucosae at 3 (A), 6 (B) and 10 (C) dpi. Only the top 20 up- and down-regulated genes in
metabolisms and maintenance categories are listed in (B) and (C). Up-regulated genes are shown in red and down-regulated genes in blue.
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Interestingly, the genes of anti-viral ISGs were signiﬁcantly
up-regulated, targeting almost every step of virus replication
life cycle, i.e., inhibition of viral entry (IFITM1 and IFITM3);
blockade of viral disassembly (TRIM5); introduction of hypermu-
tations (APOBEC3A, APOBEC3C, APOBEC3D, APOBEC3F and APO-
BEC3G); blockade of viral DNA synthesis (SAMHD1 and MOV10);
inhibition of viral transcription (MX1, MX2, PML and SP100);
degradation of mRNA (OAS1, OAS2, OAS3 and OASL); inhibition
of protein translation (SLFN13, SLFN14, PKR and IFIT protein
family); blockade of viral Gag protein trafﬁcking (TRIM22); block-
ade of viral assembly (HERC5 and HERC6); and blockade of viral
release (ISG15, BST2/tetherin and viperin). In addition to direct
inhibition of the virus, several ISGs involved in viral suppression
through antigen presentation (PSMB8) and unknown mechanisms
(IFI44L, IFI6, IFI35, TNFSF10 and DDIT4) were also up-regulated.
Inﬂammation, immune activation and cell trafﬁcking
In addition to active IFN responses, the expression of genes
related to the mucosal proinﬂammatory responses, immune acti-
vation and immune cell trafﬁcking was also signiﬁcantly up-
regulated (Fig. 2). At 6 and 10 dpi, CXCL11, the major ligand of
CXCR3, was the most up-regulated cytokine, with greater than 100-
fold up-regulation at 10 dpi. Other CXCR3 ligands (CXCL10 and
CXCL9) were among the most up-regulated DEGs. DEGs encoding
CCR5 ligands (CCL3/MIP-1α, CCL3L1, CCL5/RANTES and CCL8/MCP-2)
were also up-regulated. Other important chemoattractant genes for T
cells (CXCL1, CCR1, CCL13 and CCL8), myeloid dendritic cells (CCL19
and CCL21), monocytes (CCR1, CCL2, CCL13 and CCL8), and neutro-
phils (CXCL1, FPR3) were signiﬁcantly up-regulated. Moreover, adhe-
sion/homing receptor L-selectin (SELL/CD62L) and receptor CCR7,
which control the migration of memory T cells to inﬂamed tissues,
were up-regulated, suggesting the augmentation of T cell migration
to the rectal mucosa. Notably, among the DEGs, IL18 was down-
regulated, and IL18 inhibitor (IL18BP) and the immune suppressive
molecule CD274/PD-L1 were up-regulated.
Complement and Fc receptor activation
In line with increased inﬂammatory responses and immune
activation, complement and Fc receptor genes (PTX3 and CD93/
C1QR) were altered in expression at 6 dpi, and many more genes
in this category were altered in expression at 10 dpi, such as
components of the complement classical pathway (C1R, C1S, PTX3,
CLEC1A), lectin pathway (CLEC1A, FCN1, FCN2), alternative path-
way (CFB), or common factors shared by these pathways (C3 and
C4), and Fc receptors for IgE (FCER1A) and IgG (FCGR1, FCGR3). All
of the above DEGs were up-regulated except FCER1A (2.5-fold).
Antigen presentation
Interestingly, DEGs highlight the activation of MHC class I
antigen presentation. TAP1, TAP2, PSMB8/LMP7/β5i and PSMB9/
LMP2/β1i, members of the antigen-processing machinery (APM),
were up-regulated. PSMB8 and PSMB9, both induced by IFN-γ, are
Fig. 3. Differentially expressed genes related to IFN signaling in rectal mucosae at 6 and 10 dpi. IFN-stimulated genes are classiﬁed based on their functions. The levels
of up-regulation are color-coded based on log2 (fold change).
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integral components of the immunoproteasome where peptides
are generated and transferred to the endoplasmic reticulum to
form peptide-MHC class I complexes. Consistent with enhanced
peptide processing and transportation, MHC class I α-chain
(MAMU-A, MAMU-AG, MAMU-B, MAMU-E, MAMU-F, MAMU-I)
and β-chain (B2M) genes were also up-regulated.
Mapping the DEGs to rectal mucosa in vivo
To validate the elevated expression of DEGs and determine
their spatial distribution in the rectum, we performed immuno-
histochemical staining (IHCS) of IFITM3, a recently identiﬁed anti-
viral factor, and Mx1, one of the most up-regulated genes during
early SIV infection. Consistent with the mRNA-seq data, IFITM3
and Mx1 proteins were signiﬁcantly elevated in the lamina propria
at 6 dpi (13- and 25-fold, respectively) and 10 dpi (28- and 63-fold,
respectively) (Fig. 4) as compared with the rectal mucosa of SIV-
uninfected macaques.
SIV genome-wide expression
To better understand the genome-wide transcription pattern of
SIV in vivo in early rectal infection, we mapped virus mRNA-seq
reads to the SIVmac251 reference genome and calculated the read
coverage at each nucleotide position. There was no signiﬁcant
difference between 3 dpi and the uninfected control for read map-
ping, indicating that mRNA-seq approach is less sensitive for detect-
ing viral replication than qRT-PCR and ISH. As shown in Fig. 5, SIV
mRNA was readily detectable at 6 dpi and increased further at 10 dpi
using mRNA-seq, which is consistent with our qRT-PCR and ISH data
(unpublished data). The mRNA levels of different SIV genes were not
equivalent: genes encoding Env and accessory proteins (Vif, Vpu, Vpr,
Vpx and Nef) were much higher than those of Gag and Pol in
expression. For read coverage, there were larger peaks and valleys in
the Env and Nef than the Gag and Pol regions. While the peaks
reﬂected high levels of Env and Nef mRNAs, the valleys indicated
that, in the transmitted/founder viruses in rhesus rectal mucosa,
there were sequence polymorphism in env and nef genes, mis-
matched to SIVmac251 reference genome.
Fig. 4. Expression of MX1 and IFITM3 proteins in rectal mucosa. (A) Representative IHCS of MX1 and IFITM3 in uninfected control and SIV-infected rhesus macaques.
(B) Quantiﬁcation of MX1 and IFITM3 levels in rectal mucosa of all rhesus macaques in this study. Bar¼100 μm.
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Discussion
The anorectal mucosa is a major entry site in HIV-1 transmis-
sion, especially among men who have sex with men (MSM).
To shed light on the mechanism of HIV-1 rectal transmission, we
employed next-generation mRNA-seq and studied virus–host
interactions in the rectal mucosa during very early infection.
We found that there are robust host rectal mucosal responses
to early rectal SIV transmission. At 3 dpi when SIV replication was
still restricted within the portal of entry and before systemic
dissemination, inﬂammation-related genes (CCL13, CCL20, CD1D,
CNTFR, FDCSP, and NOS2) were signiﬁcantly up-regulated. CCL13 is
known for chemotaxis of monocytes, T cells, natural killer (NK)
cells and immature dendritic cells, and CCL20 for T cells, B cells
and immature dendritic cells. Strikingly, we found that the
chemoattractant genes CCL13 and CCL20 were up-regulated at
both 3 and 6 dpi. Up-regulated CCL20 and CCL13 gene expression
in the rectal mucosa suggests that these chemokines may play a
key role in recruiting virus-susceptible target cells to the rectal
mucosa in the very early stage of transmission.
The early immune responses to rectal SIV exposure are initiated
by PRRs that recognize SIV PAMPs. Viral RNA pattern recognition
genes (RIG-I, LGP2, MDA5, DDX60, TLR3, and TLR7) were up-
regulated at 6 and 10 dpi. RIG-I is a key PRR that triggers IFN
expression after detection of double-stranded RNA with a 50
triphosphate (50ppp-dsRNA) (Kowalinski et al., 2011). A recent
report suggested that LGP2 acts upstream of RIG-I and MDA5 to
facilitate their recognition of viral dsRNA (Satoh et al., 2010).
DDX60 was recently reported to be an antiviral factor that
interacts with RIG-I, MDA5 and LGP2 and regulates RIG-I- and
MDA5-mediated type I IFN activation after viral infection
(Miyashita et al., 2011). Moreover, genes involved in viral DNA
recognition (DAI, IFI16 and AIM2) were signiﬁcantly up-regulated
at 10 dpi, reﬂecting the presence of viral DNA in the cytoplasm
after reverse transcription of SIV genomes, and previous studies
showed that the presence of DNA in cytoplasm is a danger signal
and can trigger defense responses in eukaryotic cells (Barbalat
et al., 2011; Thompson et al., 2011). Surprisingly, in addition to
recognition of viruses, receptors recognizing bacteria (MARCO,
NOD2 and TLR2) were also up-regulated at 10 dpi, which suggests
that the rectal mucosal barrier may be compromised, allowing
bacteria and/or their products cross over. This speculation is
consistent with our previous ﬁnding of increased intestinal
epithelial cell apoptosis during early SIV infection (Li et al., 2008).
Our results revealed that after sensing PAMPs, the host's rectal
mucosa mounted two major responses: (1) activation of IFN
signaling and antiviral responses and (2) inﬂammation, cell
trafﬁcking and immune activation. As shown in Fig. 3, the IFN
signaling pathway (STAT1, STAT2, SOCS1, SOCS3, IFN-α, IFN-γ, IRF1
and IRF7) was signiﬁcantly activated, and antiviral IFN-stimulated
genes (ISGs) were induced at both 6 and 10 dpi. IRF1 plays a
crucial role in regulating MAVS-dependent signaling from peroxi-
somes (Dixit et al., 2010) and induces the expression of ISGs in the
absence of IFN signaling, thereby demonstrating broad-spectrum
anti-viral activity (Schoggins et al., 2011). IRF7 can induce the
expression of ISGs in the absence of IFN; therefore, the cell can
produce rapid ISG expression before IFN is produced (Schmid et
al., 2010), which may explain the high levels of ISGs as early as
6 days after SIV infection. Suppressor of cytokine signaling (SOCS)
genes, which negatively regulate type I IFN signaling, were also
up-regulated. It has been demonstrated that HIV-1 can exploit this
mechanism by inducing SOCS3 expression in macrophages, result-
ing in the failure of IFN-β to suppress viral replication (Akhtar et
al., 2010). Cytosolic DNAs are sensed, triggering IFN-β expression
through STING (Barber, 2011), which was also up-regulated at
10 dpi.
As shown in Fig. 3, the products of up-regulated ISGs possess
broad antiviral activities targeting each step of the viral life cycle,
which we will discuss in categories based on their mechanisms:
(1) Inhibition of viral entry. IFITM1 and IFITM3 were up-regulated.
It is now clear that IFITM1, 2 and 3 have anti-inﬂuenza activity
(Brass et al., 2009), and a recent study showed that IFITM3 inhibits
HIV-1 replication in vitro (Schoggins et al., 2011); (2) Blocking of
virus disassembly. TRIM5 was up-regulated. TRIM5 can inhibit
HIV/SIV replication by prematurely accelerating viral capsid dis-
assembly (Song et al., 2005; Stremlau et al., 2006). In addition to
disruption of viral disassembly, binding of TRIM5 to the HIV-1
capsid catalyzes the synthesis of free ubiquitin chains, leading to
AP-1 and NF-κB activation (Iwasaki, 2012); (3) Hypermutation of
viral genomes. Many apolipoprotein B editing catalytic subunit-
like 3 family (APOBEC3) genes (A, C, D, F, G and H), which have
cytidine deaminase (CDA) domains and can induce G-to-A hyper-
mutations in viral DNA during reverse transcription, thereby
impairing virus infectivity, were signiﬁcantly up-regulated at
10 dpi (Bishop et al., 2004). APOBEC3G and APOBEC3F restrict
the replication of HIV-1 by introducing hypermutations in the viral
genome (Zheng et al., 2004). APOBEC3C is an SIV inhibitor (Yu et
al., 2004) and was the most up-regulated (6-fold) member of the
Fig. 5. Transcriptome analysis of SIV replication in rhesus macaques. Coverage of mRNA-seq reads at each position of the SIV genome at 6 dpi and 10 dpi.
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APOBEC3 family at 10 dpi. A recent study showed that APOBEC3A
inhibits early phases of HIV-1 infection by decreasing viral DNA
accumulation (Berger et al., 2011); (4) Blocking of reverse tran-
scription. SAM domain HD domain-containing protein 1
(SAMHD1) can block reverse transcription of HIV-1 by depleting
the intracellular pool of deoxynucleoside triphosphates (dNTPs)
(Lahouassa et al., 2012). MOV10 can be packaged into HIV-1
virions and inhibit reverse transcription after viral entry into host
cells (Abudu et al., 2012); (5) Inhibition of viral transcription. Mx1,
Mx2, PML and Sp100 were up-regulated. After assembly into
multimers, GTPases Mx1 and Mx2 inhibit transcription and inter-
fere with viral particle assembly. Sp100 is a major component of
nuclear domain 10 (ND10), which harbors multiple functions,
including viral inhibition by transcriptional repression (Tavalai
and Stamminger, 2009); (6) Degradation of viral RNA. OAS1,
OAS2, OAS3 and OASL, which can synthesize oligo-A, in turn
binding and activating RNase L and leading to mRNA degradation,
were signiﬁcantly up-regulated (Ishibashi et al., 2010); (7) Inhibi-
tion of translation. PKR/EIF2AK2, IFIT1/ISG56, IFIT1B, ITIT2, IFIT3,
and IFIT5 were signiﬁcantly up-regulated at both 6 and 10 dpi.
PKR/EIF2AK2 is induced by IFN-β and activated by dsRNA (Der et
al., 1998). Once activated, PKR inhibits all protein synthesis in the
cell via phosphorylation of the translation initiation factor eIF2α.
IFIT1/ISG56, IFIT1B, ITIT2, IFIT3, and IFIT5 are functionally related,
containing IFN-stimulated response elements (ISREs) for gene
transcription after IFN activation and can also be triggered by
PAMPs before the induction of type I IFNs (Diamond and Farzan,
2013). A recent study demonstrated that IFIT1 and IFIT3 possess
antiviral functions (Guo et al., 2000). IFIT1 can inhibit translation
by binding to eukaryotic initiation factor 3 (eIF3) and also prevents
viral replication by targeting viral 50 triphosphate-RNAs (PPP-RNA)
for destruction (Pichlmair et al., 2011). To escape the inhibition of
IFIT1, inﬂuenza virus has evolved to express large quantities of
short ppp-RNA to avoid restriction (Umbach et al., 2010). It will be
interesting to investigate whether HIV and SIV possess a similar
mechanism to escape inhibition by IFIT proteins; (8) Blocking of
Gag trafﬁcking. TRIM22, which can inhibit HIV-1 replication by
blocking intracellular trafﬁcking of HIV-1 Gag to the cell surface,
was up-regulated (Barr et al., 2008); (9) Blocking of virus assem-
bly. USP18 and HERC5 were signiﬁcantly up-regulated. HERC5 is
the major enzyme mediating the conjugation of ISG15 to more
than 100 proteins in IFN-stimulated cells. A recent study showed
that human HERC5 arrests HIV-1 assembly at the plasma mem-
brane via conjugation of ISG15 to Gag protein (Woods et al., 2011).
After SIV infection, the HERC5 gene was up-regulated 8.8- and 29-
fold at 6 dpi and 10 dpi, respectively, which may help the host cell
contain the release of SIV; (10) Blocking of virus release. Tetherin/
BST-2, ISG15, and viperin were signiﬁcantly up-regulated at both
6 and 10 dpi. Tetherin/BST-2 is an IFN-α-induced protein localized
to the cell surface and is critical for the antiretroviral activity of
type I IFN in vivo (Liberatore and Bieniasz, 2011). Tetherin/BST-2
efﬁciently inhibits retroviral release by trapping virions on the cell
surface (Neil et al., 2008). ISG15 gene was one of the most up-
regulated genes, and expression of ISG15 inhibits the ubiquitina-
tion of HIV Gag protein and other host proteins, resulting in
impaired viral budding from the host cell (Okumura et al., 2006).
Moreover, ISG15 plays a critical role in the host's response against
other viral infections (Lenschow, 2010).
It should be noted that some of the above discussed viral
restriction factors were shown to inhibit viruses other than SIV
and HIV. Their inhibition mechanisms on SIV and HIV might be
different, and therefore need to be further studied. As the top up-
regulated genes at 6 and 10 dpi, the IFIT protein family members
very likely contribute to SIV inhibition. And other factors may also
have more mechanisms of viral restriction than we currently
know, such as MX2 gene, which was up-regulated 75-fold at10 dpi
and was recently shown to inhibit HIV-1 DNA integration (Liu et
al., 2013). It will be interesting to study the kinetics of expression
levels and patterns of the restriction factors in various cell types to
further elucidate interactions between host and virus.
Besides the well-studied anti-viral factors, our study also
revealed DEGs with similar levels of up-regulation as top altered
restriction factors, for example IFI44L, IFI6, PLA2G4C, USP18, LY6E
etc. (Table S1). Previous high through-put screening showed that
IFI6 inhibits yellow fever virus and IFI44L inhibits hepatitis C virus
(HCV), whereas LY6E signiﬁcantly enhances yellow fever virus
(YFV) infection (Schoggins et al., 2011). And PLA2G4C and USP18
were both reported to facilitate HCV replication (Randall et al.,
2006; Xu et al., 2012). While the effects of up-regulated levels of
IFI44L and IFI6 on SIV replication in vivo need to be further
investigated, PLA2G4C, USP18 and LY6E, together with some DEGs
identiﬁed in this study, might represent positive forces from host
that facilitate SIV replication.
Despite potent antiviral responses presented in rhesus rectal
mucosa, SIV still ﬁnds ways to overcome the restrictions and
expand locally and disseminate systemically. The possible mech-
anisms may be the followings. First, SIV preferentially expresses
abundant accessory genes during very early rectal infection as
revealed by mRNA-seq (Fig. 5). The SIV accessory gene products
are known to antagonize host intrinsic and innate anti-viral
molecules. The high levels of accessory gene products (Vif, Vpu,
Vpr, Vpx and Nef) antagonize the restriction from host cells and
facilitate viral replication. SIV Vpx protein binds SAMHD1 and
recruits the ubiquitin ligase complex, resulting in SAMHD1 degra-
dation in the proteasome (Blanco-Melo et al., 2012), and also
counteracts APOBEC3A by inducing its degradation (Berger et al.,
2011). Vif binds APOBEC3 proteins and results in its degradation in
the proteasome (Blanco-Melo et al., 2012). HIV-1 Vpu and SIV Nef
bind tetherin/BST-2, resulting in its sequestration and degradation
(Blanco-Melo et al., 2012). Vpr and Vif interact with cullin-
associated ubiquitin complex and target IRF3 for degradation,
resulting in the inhibition of IFNβ synthesis (Okumura et al.,
2008). Second, some altered host genes in expression revealed in
this study might facilitate SIV replication, just like the factors
identiﬁed to enhance the replication of other viruses (Randall et
al., 2006; Xu et al., 2012), PLA2G4C and USP18 are potential factors
in this category. Third, the signiﬁcantly up-regulated genes related
to the mucosal proinﬂammatory responses, immune activation
and immune cell trafﬁcking may facilitate SIV replication by
attracting CCR5þ CD4þ T cells to the rectal mucosa (Fig. 2).
Collectively, our study revealed for the ﬁrst time robust
responses in rhesus rectal mucosa during very early rectal trans-
mission of SIV, including pattern recognition, complement, inﬂam-
mation, IFN signaling and innate antiviral responses. The DEGs we
identiﬁed in this study include all the previous known anti-HIV
factors, and potential HIV-1 restriction factor candidates. Further-
more, our study revealed genome-wide SIV expression in vivo in
early rectal infection. Together, this ﬁrst comprehensive genome
wide study of early host and SIV interaction in rectum provides
new insights into the mechanism of rectal transmission and
identiﬁes potential targets for future study to validate and block
this route of transmission.
Materials and methods
Rhesus macaques and rectal SIV inoculation
Thirteen adult male rhesus macaques (Macacca mulatta) of
Indian origin housed at BIOQUAL, Inc. in accordance with the
regulations of the American Association for Accreditation of
Laboratory Animal Care standards were used in this study.
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All animals were tested negative for HIV-2, SIV, type D retrovirus,
and SRV-1 infections. Infectious SIVmac251 swarms, provided by
Dr. Nancy Miller at NIAID, NIH, were propagated in PBMC of rhesus
macaques. Ten macaques were intra-rectally inoculated with
SIVmac251 (3.4104 TCID50) and were euthanized at 3 days (3
macaques), 6 days (4 macaques) or 10 days (3 macaques) post-
inoculation. Three macaques without virus inoculation served as
uninfected controls. Rectal tissues were frozen in liquid nitrogen
immediately after dissection and stored at 80 1C until analysis.
RNA extraction and next-generation sequencing
At necropsy, the anus and rectum were cut open, divided into
six strips with 1.5 cm in length numbered from anus upward, and
the third strip was further cut into 1.5 cm0.5 cm pieces for
ﬁxation or snap frozen for RNA extraction. For RNA extraction, one
or two pieces of frozen rectum sample from strip 3 were used
depending on yield of RNA extracted. Total RNA was extracted
according to our previously published protocol (Li et al., 2009b).
Brieﬂy, rectal tissues were homogenized with a power homogeni-
zer in TRIzol (cat #15596-018, Invitrogen) and further puriﬁed
using the RNeasy Mini Kit (cat #74104, Qiagen). RNA quality was
veriﬁed on a Bioanalyzer 2100 (Agilent, Palo Alto, CA). A total of
10 μg RNA from each monkey were used for downstream pre-
paration for deep-sequencing. mRNA-seq libraries were generated
using the Sample Prep Kit (cat #FC-122-1001, Illumina Inc.)
according to the manufacturer's instructions. Brieﬂy, mRNAs were
puriﬁed from total RNA using oligo-dT magnetic beads, fragmen-
ted, and reverse transcribed into cDNAs, which went through an
end-repair process followed by ligation to adapters. A single DNA
fragment was enriched by PCR and used for sequencing on an
Illumina Genome Analyzer IIx (GA IIx) sequencer at the Genomics
Core Research Facility at the University of Nebraska-Lincoln. Each
of the 13 samples sequenced had approximately 30 million 76-
nucleotide single-end reads, and the sequencing results passed
quality control. The raw data were deposited in the Sequence Read
Archive (SRA) of the National Center for Biotechnology Informa-
tion (NCBI) under accession number SRX270636.
Transcriptome data analysis
Reads from each sample were mapped to the rhesus macaque
genome (Mmul_051212) and SIVmac251 full-length reference
sequences using GSNAP program (Wu and Nacu, 2010) with
default parameters, and the resulting SAM ﬁles were converted
to BAM ﬁles using SAMtools (Li et al., 2009a). Integrative Genomics
Viewer (IGV) (Thorvaldsdottir et al., 2013) was used for visualiza-
tion and mapping quality checking. For rhesus transcriptome
analysis, Java Picard utilities were used to count the number of
reads mapped to each gene annotated in the rhesus macaque
reference genome. The read count data were then statistically
analyzed using the DESeq package, which implements an
extended negative binomial distribution model (Anders and
Huber, 2010). Genes with adjusted p-value (Benjamini–Hochberg
method) lower than 0.05 and a fold change greater than two were
deﬁned as differentially expressed genes (DEGs), which were
further analyzed using IPA (Ingenuity Systems, www.ingenuity.
com), DAVID (http://david.abcc.ncifcrf.gov/) and literature search
for gene categorization and pathway activation. To analyze the
level of SIV mRNA, reads mapped to the SIVmac251 reference
sequence were counted base-by-base using SAMtools. The count
data were normalized based on total reads in each sample,
averaged and plotted to show the different levels of reads coverage
at 6 dpi and 10 dpi.
Immunohistochemical staining and quantitative image analysis
Rectal tissues were dissected from euthanized monkeys and
immediately ﬁxed in SafeFix II (cat# 23-042-600, Fisher Scientiﬁc)
and embedded in parafﬁn. Antibodies against IFITM3 (1:5000
dilution; cat# 3776-1, Epitomics Inc.) and MX1 (1:3000 dilution;
cat# ab95926, Abcam) were used for immunohistochemical stain-
ing (IHCS) by following procedures described previously (Li et al.,
2005). The stained slides were digitized using ScanScope (Aperio,
Vista, CA). For quantitative image analysis, the images of slides
were imported into ImageScope, and regions of laminar propria
were selected using ImageScope drawing tools. IFITM3þ or MX1þ
cells were quantiﬁed using a positive pixel count algorithm in the
Spectrum Plus analysis program (version 9.1). The parameters of
the algorithm were manually tuned to accurately match the
IFITM3þ or MX1þ markup image over the background DAB stain.
Once the parameters were set, the algorithm was applied auto-
matically to all images to measure IFITM3þ or MX1þ positive
signals by area.
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